Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional probe finds
Alnylam posts positive results of groundbreaking phase 3 PH1 trial
Feds target Medtronic in ventilator antitrust investigation
FDA expands probe into safety of AstraZeneca's COVID vaccine
*please scroll down for all the latest news*
